Fulcrum Therapeutics Inc. (FULC)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
3. 65
+0.15
+4.2857%
$
194.26M Market Cap
- P/E Ratio
- Div Yield
2.3M Volume
-1.75 Eps
$ 3.5
Previous Close 
Want to track FULC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
FULC Earnings Reports FAQ
What is the earnings per share (EPS) for FULC?
The current EPS is -1.75.
What is the company's earnings growth rate?
Fulcrum Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Fulcrum Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Fulcrum Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for FULC at this time, as Fulcrum Therapeutics Inc has no recent EPS data to calculate it.
